Makers Laboratories Ltd
BSE:506919
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
M
|
Makers Laboratories Ltd
BSE:506919
|
734.6m INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Makers Laboratories Ltd
Glance View
Makers Laboratories Ltd. is a pharmaceutical company, which engages in manufacturing and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 145 full-time employees. The firm is engaged in the manufacturing and marketing of pharmaceuticals. The Company’s segments include Pharmaceutical and Chemical Manufacturing. Its product portfolio covers a range of General Health Therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB (a-b Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). The firm also provides a range of diabetic and hypertensive drugs including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), Hypernorm range (Telmisartan). Its Inspira retail packs division includes anthelmintics, anti-allergic, anti-biotics, anti-diabetics, anti-diarrheal, anti-fungal, anti-hypertensives, anti-inflammatory, analgesic, antispasmodic. Its Experia bulk packs division includes Betamethasone 0.5 mg Tablets, Chloramphenicol Capsules 250 mg, and Chloroquine Phosphate 250 mg Tablets.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Makers Laboratories Ltd is 4.2%, which is above its 3-year median of 0%.
Over the last 3 years, Makers Laboratories Ltd’s Operating Margin has increased from 4% to 4.2%. During this period, it reached a low of -3.3% on Mar 31, 2024 and a high of 4.2% on Oct 30, 2025.
